LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Survival Benefits From Metformin Use in Pancreatic Cancer: A Systemic Review and Meta-analysis.

Photo from wikipedia

4 cases of pancreatitis (1.98%). In these cases, the admission length of stay was 4, 7, 14, and 15 days. This subgroup of patients with pancreatitis had a significantly longer… Click to show full abstract

4 cases of pancreatitis (1.98%). In these cases, the admission length of stay was 4, 7, 14, and 15 days. This subgroup of patients with pancreatitis had a significantly longer inpatient stay than that noted by Wadhwa et al. Therefore, perhaps further study is required in understanding the length of stay in hospital and therefore cost by subdividing pancreatitis by etiology. In conclusion, DBE is an iatrogenic cause of acute pancreatitis. It is of interest that post-DBE pancreatitis patients had a significantly longer admission than average and that although there is an overall improving trend on length of admission, it may be that this shorter stay is only seen in specific causes of pancreatitis.

Keywords: survival benefits; metformin use; pancreatic cancer; cancer systemic; benefits metformin; use pancreatic

Journal Title: Pancreas
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.